Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 33657295

Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2021 Mar 4
First author
Choueiri TK

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur Urol. 2021 Aug;80(2):256-257. doi: 10.1016/j.eururo.2021.04.039.
    note
    Source null
    related pmid
    33992475
    relationship
    Comment in
  2. citation
    Aktuelle Urol. 2022 Feb;53(1):16-18. doi: 10.1055/a-1559-4893.
    note
    Source null
    related pmid
    35078256
    relationship
    Comment in
  3. citation
    Eur Urol Oncol. 2023 Jun;6(3):331-338. doi: 10.1016/j.euo.2023.01.011.
    note
    Source null
    related pmid
    36797084
    relationship
    Comment in

Authors and identifiers

  1. name
    Choueiri TK
    type
    Author
  2. name
    Powles T
    type
    Author
  3. name
    Burotto M
    type
    Author
  4. name
    Escudier B
    type
    Author
  5. name
    Bourlon MT
    type
    Author
  6. name
    Zurawski B
    type
    Author
  7. name
    Oyervides Juárez VM
    type
    Author
  8. name
    Hsieh JJ
    type
    Author
  9. name
    Basso U
    type
    Author
  10. name
    Shah AY
    type
    Author
  11. name
    Suárez C
    type
    Author
  12. name
    Hamzaj A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Choueiri TK
    type
    Author
  2. name
    Powles T
    type
    Author
  3. name
    Burotto M
    type
    Author
  4. name
    Escudier B
    type
    Author
  5. name
    Bourlon MT
    type
    Author
  6. name
    Zurawski B
    type
    Author
  7. name
    Oyervides Juárez VM
    type
    Author
  8. name
    Hsieh JJ
    type
    Author
  9. name
    Basso U
    type
    Author
  10. name
    Shah AY
    type
    Author
  11. name
    Suárez C
    type
    Author
  12. name
    Hamzaj A
    type
    Author
bibliography ids
  1. nci-bib-8f20501fa8971c2dab30dac2
book metadata
content sha256
36ba2ee4318022507b814c6e4413e3c45e0817648afa531f6505acb5d7fd0680
document type
citation
dois
  1. 10.1056/NEJMoa2026982
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:33657295
immutable id
pubmed:33657295@36ba2ee4318022507b814c6e4413e3c45e0817648afa531f6505acb5d7fd0680
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
9
name
The New England journal of medicine
nlm unique id
0255562
pages
829-841
volume
384
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Eur Urol. 2021 Aug;80(2):256-257. doi: 10.1016/j.eururo.2021.04.039.
    note
    Source null
    related pmid
    33992475
    relationship
    Comment in
  2. citation
    Aktuelle Urol. 2022 Feb;53(1):16-18. doi: 10.1055/a-1559-4893.
    note
    Source null
    related pmid
    35078256
    relationship
    Comment in
  3. citation
    Eur Urol Oncol. 2023 Jun;6(3):331-338. doi: 10.1016/j.euo.2023.01.011.
    note
    Source null
    related pmid
    36797084
    relationship
    Comment in
outcomes validated
false
pmid
33657295
provenance
batch id
79f1021053e858d13ff3
provider
NCBI PubMed ESummary
record sha256
e045da7be728bfb130c96874bd131d3e21f940b4339175ad7f7ab3fe41f454f1
response sha256
671d3d2962f73c698a1cb338d73222e2cc6cfdf61569f91b42612d5b59822e05
retrieved at
2026-09-09T23:47:59.098265+00:00
publication date
display
2021 Mar 4
precision
day
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Comparative Study
  3. Journal Article
  4. Multicenter Study
  5. Randomized Controlled Trial
  6. Research Support, N.I.H., Extramural
  7. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/33657295/
title
Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.

Preserved source evidence · Not medical advice